| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Australia | 4 | |
| #3 | Canada | 4 | |
| #4 | China | 4 | |
| #5 | EPO (European Patent Office) | 4 | |
| #6 | Republic of Korea | 4 | |
| #7 | United States | 3 | |
| #8 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Macromolecular chemistry and polymers | |
| #3 | Biotechnology | |
| #4 | Organic fine chemistry | |
| #5 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Specific use of cosmetics | |
| #4 | Microorganisms | |
| #5 | Macromolecular compounds compositions | |
| #6 | Polysaccharides | |
| #7 | Peptides | |
| #8 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Nistor Gabriel | 25 |
| #2 | Cornforth Andrew N | 6 |
| #3 | Dillman Robert O | 6 |
| #4 | Nistro Gabriel | 3 |
| #5 | Dillman Robert | 2 |
| #6 | Andrew N Cornforth | 1 |
| #7 | Gabriel Nistor | 1 |
| #8 | Robert O Dillman | 1 |
| #9 | Cornforth Andrew | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021022155A1 | Soluble programmed cell death protein-1 as a biomarker in cancer patients | |
| KR20200116906A | Use of cell membrane-bound signaling factors | |
| KR20190115080A | Methods for Promoting Tumor Immunogenicity and Compositions for Autologous Cancer Immunotherapy Products Using Modified Tumor Cells and Modified Dendritic Cells | |
| CN110248648A | The application of the cell membrane binding signal factor |